Reduction and Prevention of the Cardiovascular Sequelae of the Insulin Resistance Syndrome

Publisher： Bentham Science Publishers

E-ISSN： 1875-5895|1|2|107-120

ISSN： 1568-0061

Source： Current Drug Targets - Cardiovascular & Hematological Disorders, Vol.1, Iss.2, 2001-12, pp. : 107-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Familial Partial Lipodystrophy: A Monogenic Form of the Insulin Resistance Syndrome

By Hegele R.A.  

Molecular Genetics and Metabolism, Vol. 71, Iss. 4, 2000-12 ,pp. : 539-544

Academic Press

Access to resources Recommend Favorite

The Effect of Modified-Release Ketoconazole on Insulin Resistance in Patients with Severe Metabolic Syndrome

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 12, Iss. 1, 2012-03 ,pp. : 64-72

Bentham Science Publishers

Access to resources Recommend Favorite

The Fatty Liver and Insulin Resistance

By  

Current Molecular Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 287-295

Bentham Science Publishers

Access to resources Recommend Favorite

Recognition and Prevention of Cardiovascular Disease in Women

By Champney Kimberly P.   Wenger Nanette K.  

Comprehensive Therapy, Vol. 31, Iss. 4, 2005-12 ,pp. : 255-261

Humana Press, Inc

Access to resources Recommend Favorite

Genetic Lipodystrophies: Models for Insulin Resistance

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 2, Iss. 4, 2002-12 ,pp. : 245-250

Bentham Science Publishers

Access to resources Recommend Favorite